跳至主要内容
临床试验/EUCTR2006-003502-26-GB
EUCTR2006-003502-26-GB进行中(未招募)1 期

A randomised control trial of the use of Epoetin Beta in the treatment of Post Transplant Anaemia - Epoetin Beta in PTA

Barts and the London NHS Trust0 个研究点目标入组 0 人开始时间: 2006年10月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1) Male and female patients greater than 3 months Post Kidney Transplant.
  • 2) Age >18 years and < 80 years
  • 3) Haemoglobin >9g/dl and <11.5g/dl
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Currently on an Erythropoietin Stimulating Agent
  • 2) Uncontrolled Hypertension
  • 3) Congestive Cardiac Failure
  • 4) History of Seizures
  • 5) History of thrombotic episodes
  • 6) Pregnancy
  • 7) Lactation
  • 8) Presence of systemic disease, infection or inflammatory conditions
  • 9) Hepatic Insufficiency
  • 10)Active Hepatitis
  • 11)Uncontrolled hypothyroidism
  • 12)Chronic Alcoholism
  • 13)Known hypersensitivity to the active substance in the cartridge or benzoic acid.
  • 14)Known sensitivity to Epoetin Beta

研究者

发起方
Barts and the London NHS Trust

相似试验

A randomised control trial of the use of Epoetin... | 临床试验